Salflu HFA 120 ms (25mcg+250mcg) Inhaler ( 1 pcs)

Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:

• Patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting β2-agonist or
• Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.